Rhythm Biosciences Statistics

Total Valuation

FRA:0RY has a market cap or net worth of EUR 40.28 million. The enterprise value is 39.40 million.

Market Cap	40.28M
Enterprise Value	39.40M

Important Dates

The last earnings date was Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	327.41M
Shares Outstanding	n/a
Shares Change (YoY)	+22.10%
Shares Change (QoQ)	+12.61%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	228.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.03
PB Ratio	33.08
P/TBV Ratio	54.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.39
EV / Sales	39.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.30

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.12.

Current Ratio	2.31
Quick Ratio	1.90
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-84.48

Financial Efficiency

Return on equity (ROE) is -190.14% and return on invested capital (ROIC) is -110.90%.

Return on Equity (ROE)	-190.14%
Return on Assets (ROA)	-91.40%
Return on Invested Capital (ROIC)	-110.90%
Return on Capital Employed (ROCE)	-306.15%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.36
Inventory Turnover	7.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +110.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+110.81%
50-Day Moving Average	0.08
200-Day Moving Average	0.05
Relative Strength Index (RSI)	54.92
Average Volume (20 Days)	625

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:0RY had revenue of EUR 936,105 and -3.79 million in losses. Loss per share was -0.01.

Revenue	936,105
Gross Profit	575,401
Operating Income	-3.75M
Pretax Income	-3.79M
Net Income	-3.79M
EBITDA	-3.64M
EBIT	-3.75M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 981,858 in cash and 149,095 in debt, with a net cash position of 832,762.

Cash & Cash Equivalents	981,858
Total Debt	149,095
Net Cash	832,762
Net Cash Per Share	n/a
Equity (Book Value)	1.22M
Book Value Per Share	0.00
Working Capital	701,146

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.47 million and capital expenditures -13,763, giving a free cash flow of -3.49 million.

Operating Cash Flow	-3.47M
Capital Expenditures	-13,763
Free Cash Flow	-3.49M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	61.47%
Operating Margin	-400.74%
Pretax Margin	-405.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:0RY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.10%
Shareholder Yield	-22.10%
Earnings Yield	-9.41%
FCF Yield	-8.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:0RY has an Altman Z-Score of -10.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.81
Piotroski F-Score	2